Know Cancer

or
forgot password

Single-probe Microwave Ablation of Metastatic Liver Cancer is Highly Variable and Irreproducible


N/A
18 Years
90 Years
Not Enrolling
Both
Liver Neoplasms

Thank you

Trial Information

Single-probe Microwave Ablation of Metastatic Liver Cancer is Highly Variable and Irreproducible


Inclusion Criteria:



- Unresectable metastatic liver cancer

- No invasion of major biliary structures

- No invasion of major vascular structures

- ASA score < 4

- WHO score 0-1

- Pre-operative chemotherapy is allowed

Exclusion Criteria:

- Resectable liver metastases

- Life expectancy less than 3 months

- Patients with cardiac pacemaker, cerebral aneurysm clips, implanted electronic
instruments or other metal materials

- Coagulopathy with platelet count less than 50000

- Active infectious disease

- Age below 18 years

- Pregnancy of breastfeeding

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Variability of ablation diameters

Outcome Time Frame:

within the first 7 days and 3 months after surgery

Safety Issue:

No

Principal Investigator

Baki Topal, MD, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Universitaire Ziekenhuizen Leuven

Authority:

Belgium: Federal Agency for Medicines and Health Products, FAMHP

Study ID:

kulasMWA1

NCT ID:

NCT00922181

Start Date:

August 2008

Completion Date:

April 2009

Related Keywords:

  • Liver Neoplasms
  • malignancy
  • liver
  • microwave
  • surgery
  • Neoplasms
  • Liver Neoplasms

Name

Location